Herlander Marques
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 6
-
- Chronic Myeloid Leukemia Treatments 4
- Multiple Myeloma Research and Treatments 4
- Co-authors
- Rui Medeiros (7 shared papers)Fátima Baltazar (4 shared papers)Céline Pinheiro (2 shared papers)Adhemar Longatto‐Filho (4 shared papers)Fernando Pardal (3 shared papers)Rui Manuel Reis (5 shared papers)Ana Luísa Teixeira (4 shared papers)Teresa Pereira (2 shared papers)
In The Last Decade
Herlander Marques
24 papers receiving 253 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 78
- Genetics 27
- Pathology and Forensic Medicine 40
- Oncology 44
- Hematology 18
Countries citing papers authored by Herlander Marques
This map shows the geographic impact of Herlander Marques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herlander Marques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herlander Marques more than expected).
Fields of papers citing papers by Herlander Marques
This network shows the impact of papers produced by Herlander Marques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herlander Marques. The network helps show where Herlander Marques may publish in the future.
Co-authors
The 25 scholars most cited alongside Herlander Marques, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 50 | |
| 2 | 2019 | 38 | |
| 3 | 2008 | 30 | |
| 4 | 2010 | 22 | |
| 5 | 2016 | 21 | |
| 6 | 2015 | 14 | |
| 7 | 2021 | 14 | |
| 8 | 2009 | 12 | |
| 9 | 2020 | 10 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 6 | |
| 12 | 2012 | 6 | |
| 13 | 2013 | 5 | |
| 14 | 2018 | 5 | |
| 15 | 2021 | 3 | |
| 16 | 2022 | 3 | |
| 17 | 2011 | 3 | |
| 18 | 2017 | 3 | |
| 19 | 2020 | 2 | |
| 20 | Cost-effectiveness Analysis of Rituximab Maintenance Treatment in Patients With Follicular Lymphoma who Respond to First Line Induction Therapy in Portugal | 2016 | 1 |
About Herlander Marques
Herlander Marques is a scholar working on Pathology and Forensic Medicine, Hematology, Molecular Biology, Cancer Research and Genetics, having authored 25 papers that have together received 260 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Multiple Myeloma Research and Treatments (4 papers), Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (3 papers), RNA Research and Splicing (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (78 citations), Genetics (27 citations), Pathology and Forensic Medicine (40 citations), Oncology (44 citations) and Hematology (18 citations). Herlander Marques has collaborated with scholars based in Portugal, Brazil and Canada. Frequent co-authors include Rui Medeiros, Fátima Baltazar, Céline Pinheiro, Adhemar Longatto‐Filho, Fernando Pardal, Rui Manuel Reis, Ana Luísa Teixeira, Teresa Pereira, Filipa Ventura and Raquel Catarino. Their work appears in journals such as Biomedicines, Cancers, Dermatology Research and Practice, International Journal of Molecular Sciences and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.